Status:
RECRUITING
Use of Ctdna in Patients With Gastrointestinal Tract Tumors
Lead Sponsor:
Fondazione Policlinico Universitario Agostino Gemelli IRCCS
Conditions:
Pancreas Cancer
Colon Cancer
Eligibility:
All Genders
18-85 years
Brief Summary
This study will evaluate the use of ctDNA in the clinical management of patients with tumors of the gastrointestinal tract.
Detailed Description
This is a a prospective observational single-center study; it is a spontaneous study, not sponsored by pharmaceutical companies, and does not involve the use of experimental drugs. The study involves ...
Eligibility Criteria
Inclusion
- Age \>18 years
- PS ECOG \<2;
- Histological diagnosis of gastrointestinal cancer: esophageal, gastric, intestinal, pancreatic, biliary tract neoplasms;
- Radiological evidence of resectable/locally advanced/metastatic disease on the date of signing the written informed consent;
- Adequate organ and function;
- Availability of tumor histological material.
Exclusion
- No histological diagnosis of neoplasia of the gastrointestinal tract.
- No written informed consent.
Key Trial Info
Start Date :
November 1 2023
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
November 1 2028
Estimated Enrollment :
100 Patients enrolled
Trial Details
Trial ID
NCT06202131
Start Date
November 1 2023
End Date
November 1 2028
Last Update
September 2 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Policlinico Agostino Gemelli
Rome, Lazio, Italy, 00168